Associate Director, Clinical Operations
Axsome Therapeutics Inc- Full Time
- Senior (5 to 8 years)
The Executive Director, Clinical Operations Process & Strategic Planning role at Apogee Therapeutics is a newly created position focused on ensuring the Clinical Operations organization is prepared to execute multiple global late-phase studies. This role involves assessing, planning, and implementing global processes, strategies, and solutions, analyzing current processes and systems, and providing strategic guidance on Process Excellence and Clinical Compliance. It reports into the Clinical Trial Excellence organization and will be a key leader on the Clinical Operations Leadership Team (COLT).
Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed biotechnology company founded in 2022. They are focused on developing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications with high unmet need. Apogee’s antibody programs aim to overcome limitations of existing therapies by targeting established mechanisms and incorporating advanced antibody engineering. The company is committed to building an exceptional company culture based on its C.O.R.E. values: Caring, Original, Resilient, and Egoless.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.